NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Travere Therapeutics, Inc. ( "Travere" or the "Company" ) TVTX. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Zscaler shares jump to new highs after beating earnings and revenue expectations, driven by strong demand for its Zero Trust platform. Multiple price target increases from analysts continue to come in following the company's upbeat results. Rebound or breakdown?

SALT LAKE CITY, June 02, 2025 ( GLOBE NEWSWIRE ) -- Granite Credit Union is excited to announce the official grand opening of its new Sandy Branch, located at 9383 S 700 E, Sandy, Utah 84070. The celebration will take place on Saturday, June 7, from 10 a.m. to 2 p.m.

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Eos Energy Enterprises, Inc. ( "Eos" or the "Company" ) EOSE. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of EchoStar Corporation ( "EchoStar" or the "Company" ) SATS. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Bristol Myers Squibb just agreed to shower BioNTech with cash.

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Flowco Holdings Inc. ( "Flowco" or the "Company" ) FLOC. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.

Plus, Special OUTFRONT Moments Series to Feature Legacy Photographer Peter Hujar and Spotlight Emerging LGBTQ Artists NEW YORK, June 2, 2025 /PRNewswire/ -- OUTFRONT Media Inc. OUT, one of the largest out of home ( OOH ) media companies in the United States, today announced the launch of "One ...

65% of patients on 108 mg BID Haduvio saw a 50% drop in cough frequency vs. 19% on placebo at week 6. Mean CS-NRS score dropped by 3.2 points at week 6 with 54 mg BID Haduvio vs. 1.5-point drop with placebo. Ready to turn the market's comeback into steady cash flow? Grab the top 3 stocks to buy ...

NEW YORK, June 02, 2025 ( GLOBE NEWSWIRE ) -- Pomerantz LLP is investigating claims on behalf of investors of Redwire Corporation ( "Redwire" or the "Company" ) RDW. Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.